NCPI Workmark
Articles in regional publications that pertain to a wide range of North Carolina-related topics.

Search Results


26 results for "Pharmaceutical industry"
Currently viewing results 16 - 26
Previous
PAGE OF 2
Record #:
29178
Author(s):
Abstract:
Despite pinching of a contracting economy, North Carolina's health product industry is growing and expanding. The value of products and the amount of them being produced in and shipped from North Carolina has rapidly grown in the last decade, sometimes quadrupling the numbers seen in 1980.
Source:
NC Magazine (NoCar F 251 W4), Vol. 49 Issue 2, Feb 1991, p48-51, por
Record #:
26978
Author(s):
Abstract:
Burroughs Wellcome Company discovered that the drug AZT can prolong the lives of many people with AIDS, but at an annual cost of about ten-thousand dollars per patient. North Carolina has a share of the federal safety-net program to help AIDS patients who can’t afford AZT. Others who are without federal aid are organizing boycotts against Burroughs and considering lawsuits.
Source:
Independent Weekly (NoCar Oversize AP 2 .I57 [volumes 13 - 23 on microfilm]), Vol. 6 Issue 7, Apr 7-20 1988, p7, il Periodical Website
Record #:
24413
Abstract:
The North Carolina pharmaceutical industry is rapidly expanding its research and production facilities. This article presents the top pharmaceutical companies in North Carolina and how they are helping expand the business in the state.
Record #:
32948
Author(s):
Abstract:
Health products manufacturing has become an important asset to North Carolina’s economy. A study commissioned by the North Carolina Health Products Manufacturers Association surveyed fourteen manufacturing firms which produce pharmaceuticals or medical devices. These firms are attractive because they offer high wages, increasing employment opportunities and largely pollution-free production processes.
Source:
We the People of North Carolina (NoCar F 251 W4), Vol. 42 Issue 11, Nov 1984, p16-122, por, f
Record #:
32949
Author(s):
Abstract:
Research and development (R&D) spending is the driving force of the pharmaceutical industry. Within North Carolina, resources include major research universities, the Research Triangle Institute, and the North Carolina Biotechnology Center located in the Research Triangle Park. Funding has enabled the development of new products and technologies, and profound impacts to the economy.
Source:
Record #:
32950
Author(s):
Abstract:
The pharmaceutical industry was relatively unscathed by the recession, according to Joseph E. Hoffman, Jr., plant manager of Bristol-Myers Company’s manufacturing facility in Morrisville. Demand for his plant’s products, which include pain relievers and cold medicine, are dependent on factors other than the economy. The company relies on product diversification, quality control, and ample employment opportunities.
Source:
We the People of North Carolina (NoCar F 251 W4), Vol. 42 Issue 11, Nov 1984, p24-25, il, por
Record #:
32952
Author(s):
Abstract:
Squibb Corporation’s penicillin formulation plant in Kenly is a key part of the pharmaceutical company’s worldwide network of research laboratories, manufacturing plants and distribution centers. The Kenly plant produces antibiotics in capsule and tablet formulations. Several innovations at the plant were designed to enhance pharmaceutical manufacturing efficiency and productivity.
Source:
Record #:
32953
Author(s):
Abstract:
Glaxo Inc., one of North Carolina’s newest pharmaceutical companies, moved its headquarters from Great Britain to Research Triangle Park in August 1983. Glaxo is among the world’s top twenty pharmaceutical companies and produces more than 250 products. A state-of-the-art manufacturing facility is being constructed in Zebulon, and is designed to permit additional growth and expansion.
Source:
Record #:
32954
Author(s):
Abstract:
Ajinomoto U.S.A., Inc., located in Raleigh, began operations in 1982 as the only United States plant with the technical capabilities to produce a wide variety of pharmaceutical amino acids. The Japan-based company first developed monosodium glutamate (MSG), is a leader of research, and currently holds sixty-five percent of the world’s amino acids market. Before opening in Raleigh, all amino acids were imported from Japan.
Source:
Record #:
32448
Author(s):
Abstract:
Burroughs Wellcome Foundation, Ltd., is a biomedical research foundation based in Research Triangle Park, North Carolina. The foundation has a partnership with the Duke University Medical Center and Hospital, fostering collaboration between the pharmaceutical industry and medical research.
Source:
We the People of North Carolina (NoCar F 251 W4), Vol. 38 Issue 4, Apr 1980, p20-55, il, por
Record #:
32244
Author(s):
Abstract:
The author highlights some recent NC business news, including an acquisition of a pharmaceutical company by R.J. Reynolds Tobacco Company. In other news, the Mylecraft Manufacturing Company owned by Mrs. L. V. Myles was willed to the town of Rich Square upon her death.
Source:
The State (NoCar F 251 S77), Vol. 26 Issue 13, Nov 1958, p30-31
Full Text: